Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
23andMe Holding Co. (ME)  
$0.55 0.01 (2.33%) as of 4:30 Fri 5/31


Download
   
Exchange:
Security Type:
Shares Out: 259,770,000
Market Cap: 141.63(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3901 - $2.08
Level I Sector:
Level II Sector:
Level III Sector:

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   23andMe Holding is a newly blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 192,743 424,031 864,673 918,106
Total Sell Value $94,802 $277,041 $808,123 $985,010
Total People Sold 1 1 2 4
Total Sell Transactions 5 11 23 26
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 132
  Page 3 of 6  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Taylor Peter J. Director   –       •      –    2023-09-06 4 A $0.00 $0 D/D 137,566 265,217     -
   Mohan Neal Director   –       •      –    2023-09-06 4 A $0.00 $0 D/D 154,997 245,806     -
   Hernandez Sandra R Md Director   –       •      –    2023-09-06 4 A $0.00 $49,999 D/D 194,363 337,549     -
   Montgomery Rice Valerie Md Director   –       •      –    2023-09-06 4 A $0.00 $65,000 D/D 190,495 339,544     -
   Richards William G Head of Therapeutics Discovery   •       –      –    2023-09-05 4 S $1.08 $2,741 D/D (2,538) 211,041 31%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-08-24 4 AS $1.05 $43,119 D/D (40,894) 252,512 -20%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-08-24 4 OE $0.42 $17,175 D/D 40,894 293,406     -
   Selsavage Joseph Anthony Interim CFO   •       –      –    2023-08-20 4 D $1.14 $7,078 D/D (6,209) 286,537     -
   Richards William G Head of Therapeutics Discovery   •       –      –    2023-08-20 4 D $1.14 $9,331 D/D (8,185) 211,041     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-08-20 4 D $1.14 $5,276 D/D (4,628) 252,512     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-08-15 4 AS $1.32 $53,939 D/D (40,894) 257,140 -34%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-08-15 4 OE $0.42 $17,175 D/D 40,894 298,034     -
   Richards William G Head of Therapeutics Discovery   •       –      –    2023-08-08 3 IO $0.00 $0 D/D 0 219,226 -45%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-07-27 4 AS $1.89 $77,257 D/D (40,894) 257,140 -46%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-07-27 4 OE $0.42 $17,175 D/D 40,894 298,034     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-07-13 4 AS $1.82 $74,239 D/D (40,894) 257,140 -54%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-07-13 4 OE $0.42 $17,175 D/D 40,894 298,034     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-06-29 4 AS $1.72 $70,432 D/D (40,894) 257,140 -48%     
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-06-29 4 OE $0.42 $17,175 D/D 40,894 298,034     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-06-05 4 D $2.08 $31,404 D/D (15,098) 257,140     -
   Hibbs Kathy L Chief Administrative Officer   •       –      –    2023-06-05 4 A $0.00 $0 D/D 43,659 272,238     -
   Hillan Kenneth Chief Therapeutics Officer   •       –      –    2023-06-05 4 D $2.08 $31,922 D/D (15,347) 221,876     -
   Hillan Kenneth Chief Therapeutics Officer   •       –      –    2023-06-05 4 A $0.00 $0 D/D 44,381 237,223     -
   Selsavage Joseph Anthony Interim CFO   •       –      –    2023-06-05 4 D $2.08 $27,196 D/D (13,075) 292,746     -
   Selsavage Joseph Anthony Interim CFO   •       –      –    2023-06-05 4 A $0.00 $0 D/D 37,808 305,821     -

  132 Records found
  1  2  3  4  5  6   
  Page 3 of 6
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed